Dados Bibliográficos

AUTOR(ES) P. Conrad
AFILIAÇÃO(ÕES) Brandeis University
ANO 2005
TIPO Artigo
PERIÓDICO Journal of Health and Social Behavior
ISSN 0022-1465
E-ISSN 2150-6000
EDITORA JSTOR (United States)
DOI 10.1177/002214650504600102
CITAÇÕES 110
ARQUIVOS 1
ADICIONADO EM 2025-08-18
MD5 7b4c65d66c1bec98714407e5728c35be

Resumo

Social scientists and other analysts have written about medicalization since at least the 1970s. Most of these studies depict the medical profession, interprofessional or organizational contests, or social movements and interest groups as the prime movers toward medicalization. This article contends that changes in medicine in the past two decades are altering the medicalization process. Using several case examples, I argue that three major changes in medical knowledge and organization have engendered an important shift in the engines that drive medicalization: biotechnology (especially the pharmaceutical industry and genetics), consumers, and managed care. Doctors are still gatekeepers for medical treatment, but their role has become more subordinate in the expansion or contraction of medicalization. Medicalization is now more driven by commercial and market interests than by professional claims-makers. The definitional center of medicalization remains constant, but the availability of new pharmaceutical and potential genetic treatments are increasingly drivers for new medical categories. This requires a shift in the sociological focus examining medicalization for the twenty-first century.


Ferramentas